Tech Company Financing Transactions

Remix Therapeutics Funding Round

On 12/9/2020, Remix Therapeutics raised $81 million in Series A funding from Foresite Capital, Alexandria Venture Investments and Arch Venture Partners.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series A

Foresite Capital (Lead Investor) (Michael Rome)

Alexandria Venture Investments

Arch Venture Partners (Kristina Burrow)

Atlas Venture (Kevin Bitterman)

The Column Group (Leon Chen)

Proceeds Purpose
The funds will support development of the company's REMaster technology platform and advancement of a pipeline of RNA processing targeted therapeutics.

Company Information

Company Status
Private & Independent
Mailing Address
1 Kendall Sq. Building 200
Cambridge, MA 02139
Email Address
Not Recorded
Remix Therapeutics is developing novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways. Powered by our proprietary REMaster technology platform, we can now create medicines with the unique ability to alter the way genes are read from the genome, correcting dysregulation or eliminating the gene message altogether.
Remix Therapeutics LinkedIn Company Profile
Social Media
Remix Therapeutics Company Twitter Account
Company News
Remix Therapeutics News
Remix Therapeutics on Facebook
Remix Therapeutics on YouTube

Management Team

Email & Social
Kevin Bitterman
  Kevin Bitterman LinkedIn Profile  Kevin Bitterman Twitter Account  Kevin Bitterman News  Kevin Bitterman on Facebook
Chief Operating Officer
Heather Wasserman
  Heather Wasserman LinkedIn Profile  Heather Wasserman Twitter Account  Heather Wasserman News  Heather Wasserman on Facebook
Chief Scientific Officer
Peter Smith
  Peter Smith LinkedIn Profile  Peter Smith Twitter Account  Peter Smith News  Peter Smith on Facebook
Vice President
Dominic Reynolds
  Dominic Reynolds LinkedIn Profile  Dominic Reynolds Twitter Account  Dominic Reynolds News  Dominic Reynolds on Facebook
Vice President
Jesse Smith
  Jesse Smith LinkedIn Profile  Jesse Smith Twitter Account  Jesse Smith News  Jesse Smith on Facebook
Vice President
Fred Vaillancourt
  Fred Vaillancourt LinkedIn Profile  Fred Vaillancourt Twitter Account  Fred Vaillancourt News  Fred Vaillancourt on Facebook
VP - Bus. Development
Alex Harding
  Alex Harding LinkedIn Profile  Alex Harding Twitter Account  Alex Harding News  Alex Harding on Facebook



Browse more venture capital transactions:

Prev: 12/8/2020: EPNS venture capital transaction
Next: 12/9/2020: Orca Security venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from a variety of public sources. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary